Evidence map›Paper›PMID 38130409›Full record

ArticleFrontiers in pharmacology2023

Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against

Susanne Jacobsson, Daniel Golparian, Joakim Oxelbark, Fabian Y S Kong, Renata Maria Augusto Da Costa, Francois Franceschi, David Brown, Arnold Louie, George Drusano, Magnus Unemo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 5 countries.

Susanne JacobssonWHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Daniel GolparianWHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Joakim OxelbarkDivision of Clinical Chemistry, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Fabian Y S KongCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Renata Maria Augusto Da CostaGlobal Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
Francois FranceschiGlobal Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland.
David BrownCollege of Medicine, Institute for Therapeutic Innovation, University of Florida, Orlando, FL, United States.
Arnold LouieCollege of Medicine, Institute for Therapeutic Innovation, University of Florida, Orlando, FL, United States.
George DrusanoCollege of Medicine, Institute for Therapeutic Innovation, University of Florida, Orlando, FL, United States.
Magnus UnemoWHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Örebro University · SEUniversity of Florida · USGlobal Antibiotic Research & Development Partnership · CHThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance in the sexually transmitted bacterium

Indexed as

antimicrobial treatmentdoxycyclinehollow-fiber infection modelNeisseria gonorrhoeaepharmacodynamicspharmacokineticszoliflodacin

Identifiers

PMID38130409
PMCPMC10733441
OpenAlexW4389452155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.